Cascadian Therapeutics, Inc.
Research company · Seattle, Washington, United States
Cascadian Therapeutics, Inc. is a research company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2007. It has reported private securities offerings to the US SEC, most recently $23 million sold in a notice filed in 2014.
Cascadian Therapeutics at a glance
What does Cascadian Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $22.9 million sold (2014).
Frequently asked questions about Cascadian Therapeutics
Where is Cascadian Therapeutics headquartered?
Cascadian Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
What does Cascadian Therapeutics do?
Cascadian Therapeutics, Inc. is a research company. Its SEC industry classification is Services-Commercial Physical & Biological Research.
When was Cascadian Therapeutics founded?
The earliest incorporation on record for Cascadian Therapeutics, Inc. is in 2007, according to public company registers.
Similar companies
- Icagen, Inc.Durham, North Carolina, United States
- Maxcyte, Inc.Rockville, Maryland, United States
- Absci CorpVancouver, Washington, United States
- SomaLogic, Inc.Boulder, Colorado, United States
- bioAffinity Technologies, Inc.San Antonio, Texas, United States
- iSpecimen Inc.Woburn, Massachusetts, United States
- OmniAb, Inc.Emeryville, California, United States
- Protalex IncFlorham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences